MSN LABS PVT LTD FDA Approval ANDA 212359

ANDA 212359

MSN LABS PVT LTD

FDA Drug Application

Application #212359

Application Sponsors

ANDA 212359MSN LABS PVT LTD

Marketing Status

Prescription001

Application Products

001UNKNOWNUNKNOWN0EMPAGLIFLOZIN; LINAGLIPTINEMPAGLIFLOZIN;LINAGLIPTIN

FDA Submissions

UNKNOWN; ORIG1TA2020-07-07STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

MSN LABS PVT LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212359
            [companyName] => MSN LABS PVT LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMPAGLIFLOZIN; LINAGLIPTIN","activeIngredients":"EMPAGLIFLOZIN;LINAGLIPTIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/07\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-07-07
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.